Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Feldman

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2024
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and PartnershipAndrew J Piper Vallillo, Hollis Viray, Jill Feldman, et al.
Oncology and Therapy|September 26, 2023
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and OncologistsStephen V Liu, Ivy B Elkins, Jill Feldman, et al.
JNCI Cancer Spectrum|November 6, 2024
Lung cancer-a one-way ticketDrew Moghanaki, Michelle Ann Eala, Jill Feldman, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2021
Comprehensive metastatic ablation in advanced NSCLC through biology-guided radiotherapy - A path forward?Andrea R Filippi, Marina Garassino, Shervin M Shirvani, et al.
Journal of the National Cancer Institute|May 5, 2025
Landscape assessment of patient-reported outcome item coverage of tyrosine kinase inhibitor-associated AEsEmily L Paton, Jeremy P Cetnar, Janet Freeman-Daily, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 2026
Beyond Diagnosis: Survivorship Research for People Living with Advanced and Metastatic CancersMichelle A Mollica, Jill Feldman, Lisa Gallicchio, et al.
Clinical Lung Cancer|December 30, 2025
Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal DiseaseIvy Riano, Maria A Velez, Hugo Pomares-Millan, et al.
Journal of the American College of Radiology : JACR|October 20, 2023
Enhancing Patient Communication With Chat-GPT in Radiology: Evaluating the Efficacy and Readability of Answers to Common Imaging-Related QuestionsEmile B Gordon, Alexander J Towbin, Peter Wingrove, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|August 23, 2024
Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision MedicineRamy Sedhom, Gleneara E Bates-Pappas, Jill Feldman, et al.
JTO Clinical and Research Reports|February 25, 2025
Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITYJill Feldman, Ivy Elkins, Zofia Piotrowska, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2024
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and PartnershipAndrew J Piper Vallillo, Hollis Viray, Jill Feldman, et al.
Oncology and Therapy|September 26, 2023
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and OncologistsStephen V Liu, Ivy B Elkins, Jill Feldman, et al.
JNCI Cancer Spectrum|November 6, 2024
Lung cancer-a one-way ticketDrew Moghanaki, Michelle Ann Eala, Jill Feldman, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2021
Comprehensive metastatic ablation in advanced NSCLC through biology-guided radiotherapy - A path forward?Andrea R Filippi, Marina Garassino, Shervin M Shirvani, et al.
Journal of the National Cancer Institute|May 5, 2025
Landscape assessment of patient-reported outcome item coverage of tyrosine kinase inhibitor-associated AEsEmily L Paton, Jeremy P Cetnar, Janet Freeman-Daily, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 2026
Beyond Diagnosis: Survivorship Research for People Living with Advanced and Metastatic CancersMichelle A Mollica, Jill Feldman, Lisa Gallicchio, et al.
Clinical Lung Cancer|December 30, 2025
Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal DiseaseIvy Riano, Maria A Velez, Hugo Pomares-Millan, et al.
Journal of the American College of Radiology : JACR|October 20, 2023
Enhancing Patient Communication With Chat-GPT in Radiology: Evaluating the Efficacy and Readability of Answers to Common Imaging-Related QuestionsEmile B Gordon, Alexander J Towbin, Peter Wingrove, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|August 23, 2024
Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision MedicineRamy Sedhom, Gleneara E Bates-Pappas, Jill Feldman, et al.
JTO Clinical and Research Reports|February 25, 2025
Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITYJill Feldman, Ivy Elkins, Zofia Piotrowska, et al.
Pageof 4